These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pentoxifylline in management of proteinuria in diabetic nephropathy. Tripathi K, Prakash J, Appaiha D, Srivastava PK. Nephron; 1993; 64(4):641-2. PubMed ID: 8366994 [No Abstract] [Full Text] [Related]
6. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Br Med J (Clin Res Ed); 1986 Aug 23; 293(6545):471-4. PubMed ID: 3017501 [Abstract] [Full Text] [Related]
7. Antihypertensive therapy in patients with diabetic nephropathy. Mehler PS, Schrier RW. Kidney Blood Press Res; 1997 Aug 23; 20(2):74-81. PubMed ID: 9293422 [Abstract] [Full Text] [Related]
8. The natural course of glomerular filtration rate and arterial blood pressure in diabetic nephropathy, and the effect of antihypertensive treatment. Parving HH, Andersen AR, Smidt U, Friisberg B, Bonnevie-Nielsen V, Svendsen PA. Acta Endocrinol Suppl (Copenh); 1981 Aug 23; 242():39-40. PubMed ID: 6940399 [No Abstract] [Full Text] [Related]
12. [ACE inhibitor effects on structure and function of the glomerular basement membrane]. Hasslacher C, Bostedt-Kiesel A, Kempe HP. Klin Wochenschr; 1992 Feb 08; 69 Suppl 29():39-44. PubMed ID: 1614191 [Abstract] [Full Text] [Related]
13. Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy. Kimura S, Inoguchi T, Yokomizo H, Maeda Y, Sonoda N, Takayanagi R. Diabetes Obes Metab; 2012 Jul 08; 14(7):666-9. PubMed ID: 22268518 [Abstract] [Full Text] [Related]
14. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Hommel E, Parving HH, Mathiesen E, Edsberg B, Damkjaer Nielsen M, Giese J. Br Med J (Clin Res Ed); 1986 Aug 23; 293(6545):467-70. PubMed ID: 3091164 [Abstract] [Full Text] [Related]
15. [Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy]. Nitschmann S, Girndt M, Köhler H. Internist (Berl); 2005 Aug 23; 46(8):923-4, 926. PubMed ID: 15990988 [No Abstract] [Full Text] [Related]
16. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy. Eyileten T, Sonmez A, Saglam M, Cakir E, Caglar K, Oguz Y, Vural A, Yenicesu M, Yilmaz MI. Nephrology (Carlton); 2010 Mar 23; 15(2):225-9. PubMed ID: 20470283 [Abstract] [Full Text] [Related]
19. The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure. Zander E, Conde N, Heinke P, Zander G, Strese J, Gums G, Schulz B. Exp Clin Endocrinol; 1990 Feb 23; 95(1):70-6. PubMed ID: 2335182 [Abstract] [Full Text] [Related]
20. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. Parving HH. N Engl J Med; 1994 Mar 31; 330(13):937-8. PubMed ID: 8114875 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]